Dollars in the bank as Classic Minerals transitions to production

|

Published 10-AUG-2020 11:58 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Western Australian gold exploration and development company Classic Minerals Limited (ASX:CLZ) has completed its preliminary metallurgical test work program on samples collected from drilling at Kat Gap.

The test work has been conducted on oxide and fresh mineral samples from the Kat Gap program.

The tests covered both conventional gravity and leach testing on the samples provided.

The results have been particularly encouraging, as the material tested indicated that the majority of the gold could be recovered by traditional gravity separation techniques. And, with the mineralisation located from near-surface this has the potential to provide a low processing cost option for the material.

The conventional gravity separation process has delivered up to 75% gold recovery from the oxide samples with the conventional cyanide leach process provided 95% - 96% recovery from both fresh and oxide samples.

These results are extremely positive, and the next stage of testing will focus on variability across the mineralisation and firming up the process options to deliver the indicated recoveries consistently.

The preliminary results indicate that Classic has the potential for early revenue generation through either toll treatment or self-processing of the material from Kat Gap.

The toll treating provides rapid cash flow while the onsite processing generates greater profitability as Classic can control all mining and processing costs.

400,000 ounce resource, bonanza grade gold and imminent production

Commenting on the options available and the group’s potential to boost throughput on the back of upcoming drilling, chief executive Dean Goodwin said, ‘’We are fortunate to have found, after conducting detailed research, that the metallurgical results confirm that the ore, when processed using traditional gravity and leach processes provide an outstanding gold recovery.

‘’The recent results which included 76.7 g/t gold from 79 metres and 9 metres grading 8.7 g/t gold from 14 metres give us great hope that there is the possibility of gold deposits to augment and further enhance the gold resources already determined at Kat Gap.

‘’We will be working on extending the resource with more infill drilling and then expanding the resource with extensional drilling along strike as well as in the granite.’’

One aspect that tends to be overlooked in terms of attributing a fair valuation to Classic is its established resource of more than 8.2 million tonnes grading 1.5 g/t gold for more than 400,000 ounces.

Particularly in the current gold environment, it is virtually impossible to find a company with a sizeable resource, a growing high-grade exploration deposit and imminent production for a market capitalisation of about $30 million.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X